Control of Meropenum-resistant Enterobacterace by Optimizing Infection Prevention and Control Practices

      Carbapenem-resistant Enterobacteriaceae, (CRE) was first identified in 2001, and has been found in 4.6% of all hospitals in the United States. CRE is very difficult to treat and is a threat in all hospitals if aggressive prevention measures are not rapidly instituted to protect staff, patients and visitors A proactive program emphasizing the areas of education, surveillance, isolation and prevention is the key to combat the spread of this infection in acute care facilities.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect